Natco Pharma jumps on launching first generic version of Revlimid along with Arrow International in US market
Natco Pharma is currently trading at Rs. 857.80, up by 13.50 points or 1.60% from its previous closing of Rs. 844.30 on the BSE. The scrip opened at Rs. 880.00 and has touched a high and low of Rs. 920.00 and Rs. 849.10 respectively. So far 63843 shares were traded on the counter. The BSE … Read more
